Talin-1 correlates with reduced invasion and migration in human hepatocellular carcinoma cells

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 6, 2014, Pages 2655-2661

  Fang, Kun Peng ^a   Zhang, Jian Lin ^a   Ren, Yan Hong ^a   Qian, Ye Ben ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Cell lines; HCC; Hepatocellular carcinoma; Invasion; Migration; Talin 1; Talin 2

Indexed keywords

MESSENGER RNA; TALIN; TLN1 PROTEIN, HUMAN;

CELL MOTION; DRUG SCREENING; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR INVASION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TALIN; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84899828561     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.6.2655     Document Type: Article

References (52)

1. Anthis NJ, Wegener KL, Critchley DR, et al (2010). Structural diversity in integrin/talin interactions. Structure, 18, 1654- 66.
2. Beer DG, Kardia SL, Huang CC, et al (2002). Geneexpression profiles predict survival of patients with lung adenocarcinoma. Nat Med, 8, 816-24.
3. Craig JR, Peters RL, Edmondson HA, et al (1980). Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer, 46, 372-9.
4. Calderwood DA (2004). Integrin activation. J Cell Sci, 117, 657-66.
5. Critchley DR (2004). Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. Biochem Soc Trans, 32, 831-6
6. Conti FJ, Felder A, Monkley S, et al (2008). Progressive myopathy and defects in the maintenance of myotendinous junctions in mice that lack talin 1 in skeletal muscle. Development, 135, 2043-53
7. Conti FJ, Monkley SJ, Wood MR, et al (2009). Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions. Development, 136, 3597-606
8. Debrand E, El Jai Y, Spence L, et al (2009). Talin 2 is a large and complex gene encoding multiple transcripts and protein isoforms. FEBS J, 276, 1610-28
9. Debrand E, Conti FJ, Bate N, et al (2012). Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. Biochem Bioph Res Co, 426, 190-5
10. El-Serag HB, Rudolph KL (2007). Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76
11. Fazeli Z, Pourhoseingholi MA, Vahedi M, et al (2012). Burden of hepatocellular carcinoma in Asia. Asian Pac J Cancer Prev, 13, 5955-8.
12. Farazi PA, DePinho RA (2006). Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer, 6, 674-87
13. Fornaro M, Manes T, Languino LR (2001). Integrins and prostate cancer metastases. Cancer Metastasis Rev, 20, 321-31
14. Giancotti FG, Ruoslahti E (1999). Integrin signaling. Science, 285, 1028-32
15. Hodgson HJ (1987). Fibrolamellar cancer of the liver. J Hepatol, 5, 241-7
16. Hui KM (2009). Human hepatocellular carcinoma: Expression profiles-based molecular interpretations and clinical applications. Cancer Lett, 286, 96-102
17. Ishak KG, Goodman ZD, Stocker JT (2001). Tumors of the liver and intrahepatic bile ducts. Washington, DC: Armed Forces Institute of Pathology
18. International Consensus Group for Hepatocellular Neoplasia(2009). Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia. Hepatology, 49, 658-64.
19. Kakar S, Burgart LJ, Batts KP, et al (2005). Clinicopathologic features and survival in fibrolamellar carcinoma: Comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol, 18, 1417-23.
20. Kirk GD, Bah E, Montesano R (2006). Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis, 27, 2070-82
21. Kopp PM, Bate N, Hansen TM, et al (2010). Studies on the morphology and spreading of human endothelial cells define key inter- and intramolecular interactions for talin1. Eur J Cell Biol, 89, 661-73
22. Kanamori H, Kawakami T, Effendi K, et al (2011). Identification by differential tissue proteome analysis of Talin-1 as a novel molecular marker of progression of hepatocellular carcinoma. Oncology, 80, 406-15
23. Lack EE, Neave C, Vawter GF (1983). Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer, 52, 1510-5
24. Lauwers GY, Terris B, Balis UJ, et al (2002). International Cooperative Study Group on Hepatocellular Carcinoma. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: A multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol, 26, 25-34.
25. Li Y, Tang ZY, Ye SL, et al (2001). Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol, 7, 630-6.
26. Li MS, Li PF, He SP, et al (2002). The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel-7402 cell line. World J Gastroenterol, 8, 469-75.
27. Lou CY, Feng YM, Qian AR, et al (2004). Establishment and characterization of a human hepatocellular carcinoma cell line FHCC-98. World J Gastroenterol, 10, 1462-5. Laurent-Puig P, Zucman-Rossi J (2006). Genetics of hepatocellular tumors. Oncogene, 25, 3778-86.
28. Laurent-Puig P, Zucman-Rossi J (2006). Genetics of hepatocellular tumors. Oncogene, 25, 3778-86
29. Lai MT, Hua CH, Tsai MH, et al (2011). Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis. J Pathol, 224, 367-76
30. Morris KM, Aden DP, Knowles BB, et al (1982). Complement biosynthesis by the human hepatoma-derived cell line HePG2. J Clin Invest, 70, 906-13.
31. Monkley SJ, Pritchard CA, Critchley DR (2001). Analysis of the mammalian talin2 gene TLN2. Biochem Biophys Res Commun, 286, 880-5.
32. Monkley SJ, Kostourou V, Spence L, et al (2011). Endothelial cell talin1 is essential for embryonic angiogenesis. Dev Biol, 349, 494-502.
33. Praekelt U, Kopp PM, Rehm K, et al (2012). New isoformspecific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2. Eur J Cell Biol, 91, 180-91
34. Roayaie S, Schwartz JD, Sung MW, et al (2004). Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis. Liver Transpl, 10, 534-40.
35. Schafer DF, Sorrell MF (1999). Hepatocellular carcinoma. Lancet, 353, 1253-7.
36. Song ZQ, Hao F, Min F, et al (2001). Hepatitis C virus infection of human hepatoma cell line 7721 in vitro. World J Gastroenterol, 7, 685-9.
37. Senetar MA, McCann RO (2005). Gene duplication and functional divergence during evolution of the cytoskeletal linker protein talin. Gene, 362, 141-52.
38. Senetar MA, Moncman CL, McCann RO (2007). Talin2 is induced during striated muscle differentiation and is targeted to stable adhesion complexes in mature muscle. Cell Motil Cytoskeleton, 64, 157-73
39. Slater M, Cooper M, Murphy CR (2007). The cytoskeletal proteins alpha-actinin, Ezrin, and talin are de-expressed in endometriosis and endometrioid carcinoma compared with normal uterine epithelium. Appl Immunohistochem Mol Morphol, 15, 170-4.
40. Sakamoto S, McCann RO, Kyprianou N, et al (2010). Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res, 70, 1885-95.
41. Shafizadeh N, Kakar S (2013). Hepatocellular carcinoma: Histologic subtypes. Surgical Pathology Clinics, 6, 367-84.
42. Singel SM, Cornelius C, Batten K, et al (2013). A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer. Clin Cancer Res, 19, 2061-70
43. Sriputtha S, Khuntikeo N, Promthet S, et al (2013). Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev, 14, 1107-10.
44. Takayama T, Makuuchi M, Hirohashi S, et al (1990). Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet, 336, 1150-3.
45. Takayama T, Makuuchi M, Hirohashi S, et al (1998). Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology, 28, 1241-6.
46. Tian J, Tang ZY, Ye SL, et al (1999). New human hepatocellular carcinoma(HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer, 81, 814-21.
47. Wang Z, Ruan YB, Guan Y, et al (2003). Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis. World J Gastroenterol, 9, 267-70.
48. Youns MM, Abdel Wahab AH, Hassan ZA, et al (2013). Serum talin-1 is a potential novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Asian Pac J Cancer Prev, 14, 3819-23.
49. Zavaglia C, De Carlis L, Alberti AB, et al (2005). Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol, 100, 2708-16.
50. Zender L, Spector MS, Xue W, et al (2006). Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell, 125, 1253-67.
51. Zhang X, Jiang G, Cai Y, et al (2008). Talin depletion reveals independence of initial cell spreading from integrin activation and traction. Nat Cell Biol, 10, 1062-8.
52. Zhang JL, Qian YB, Xiong QR, et al (2011). Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas. Asian Pac J Cancer Prev, 12, 3265-9.